The promise of extending healthy lifespan through eating less has captivated researchers for decades, yet translating laboratory successes to human populations remains complex. While caloric restriction consistently extends lifespan in laboratory animals from yeast to primates, human studies reveal a more nuanced picture with both benefits and potential risks that challenge simple dietary prescriptions.
This comprehensive review synthesizes evidence showing dietary restriction activates conserved cellular pathways including mTOR suppression, autophagy enhancement, and metabolic reprogramming across species. In controlled studies, moderate caloric restriction in humans improved cardiovascular markers, insulin sensitivity, and inflammatory profiles. However, the authors highlight concerning gaps: some populations experienced muscle loss, bone density reduction, and psychological stress that could offset longevity gains.
The analysis proves particularly valuable in addressing why promising animal studies often fail human translation. Species differences in metabolic rate, genetic diversity, and environmental pressures create biological contexts that don't directly transfer. The review also examines emerging pharmacological mimetics like rapamycin and metformin that potentially capture restriction's benefits without nutritional deprivation. This represents a critical shift from blanket dietary recommendations toward personalized interventions based on individual metabolic profiles and health status. The field appears to be maturing beyond simple calorie counting toward understanding which specific restriction mechanisms drive longevity benefits and how to safely harness them across diverse human populations.
